M&A Deal Summary

BioCheck Acquires DRG International

On August 18, 2021, BioCheck acquired medical products company DRG International

Acquisition Highlights
  • This is BioCheck’s 1st transaction in the Medical Products sector.
  • This is BioCheck’s 1st transaction in the United States.
  • This is BioCheck’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2021-08-18
Target DRG International
Sector Medical Products
Buyer(s) BioCheck
Deal Type Add-on Acquisition

Target

DRG International

Springfield, New Jersey, United States
DRG International is a manufacturer of DRG: HYBRiD-XL, a fully automated analyzer for Immunoassays and Clinical Chemistry. DRG International, Inc. operates in accordance with the FDA 21 CFR 820 Quality System Regulation as well as the ISO 13485:2016 and MDSAP (Medical Device Single Audit Program) by TÜV Rheinland. DRG International was founded in 1997 and is based in Springfield, New Jersey.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BioCheck

San Francisco, California, United States
Category Company
Founded 1997
Sector Medical Products
DESCRIPTION

BioCheck engaged in the development and manufacturing of quality in vitro diagnostic test kits for the worldwide biomedical, pharmaceutical, and scientific research markets under cGMP. BioCheck was founded in 1997 and is based in San Francisco, California.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Mergr

Product

Company

Legal